Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 23, 2004. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares and American Depositary Receipts (ADRs).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on equity transactions and does not contain financial performance data.
Material Changes
The filing details specific changes in shareholdings related to employee benefit plans and director interests:
- April 21, 2004: The GlaxoSmithKline Employee Trust (GSK Trust) transferred 7,510 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- April 22, 2004: The GSK Trust transferred an additional 2,666 Ordinary Shares to participants in the same plan.
- April 22, 2004: The GlaxoSmithKline US Retirement Savings Plan reduced its holding of Ordinary Share ADRs from 18,769,711 to 18,730,717 (a decrease of 38,994 ADRs) at an average price of $42.70.
Management Commentary and Risks
The filing notes that the GSK Trust and the US Retirement Savings Plan are discretionary funds where all employees or former employees are potential beneficiaries. Consequently, three directors (Dr. J-P Garnier, Dr. T Yamada, and Mr. J D Coombe) are interested in the GSK Trust shares, while two directors (Dr. J-P Garnier and Dr. T Yamada) are potentially interested in the US Retirement Savings Plan shares, in the same manner as other employees. No specific risks, contingencies, or unusual items regarding operations were disclosed in this text.
Investor Verification Checklist
- Verify the total number of shares transferred from the GSK Trust to the Employee Share Option Plan (10,176 shares total across two dates).
- Confirm the reduction in ADR holdings by the US Retirement Savings Plan and the associated average transaction price of $42.70.
- Review the specific director interests disclosed: Dr. J-P Garnier and Dr. T Yamada are linked to both the GSK Trust and the US Retirement Savings Plan, while Mr. J D Coombe is linked only to the GSK Trust.
- Note that this filing contains no operational or financial performance data; refer to Form 20-F for comprehensive financial statements.